1 |
Cole, G., Hogan, J., and Aulton, M., Pharmaceutical Coating Technology, Taylor and Francis, London, (1995)
|
2 |
Pickup, A. J., Bojanowski, L. M., Dawling, S., Dinsdale, J., and Gosling, R. G., Comparison of the effect of amitriptyline in standard and sustained-release formulations on cardiac systolic time intervals. J. Cardiovasc. Pharmacol., 4, 575-583 (1982)
DOI
PUBMED
ScienceOn
|
3 |
Rolf, T. and Harald, O. B., Determination of amitriptylin oxide and its major metabolites amitriptyline and nortriptyline in plasma by high-performance liquid chromatography. J. Chromatogr., 382, 372-376 (1986)
DOI
PUBMED
ScienceOn
|
4 |
Debbas, N., Ankier, S., and Warrington, S., Trazodone conventional and controlled-release formulations: pharmacodynamic effects after single and repeated administration. Curr. Med. Res. Opin., 11, 501 (1989)
DOI
PUBMED
ScienceOn
|
5 |
Ghahramani, P. and Lennard, M. S., Quantitative analysis of amitriptyline and nortriptyline in human plasma ans liver microsomal preparations by high-performance liquid chromatography. J. Chromatogr. B., 685, 307-313 (1996)
DOI
ScienceOn
|
6 |
Milada, D., On-line solid-phase extraction and high-performance liquid chromatographic determination of nortriptyline and amitriptyline in serum. J. Chromatogr., 579, 291-297 (1992)
DOI
PUBMED
ScienceOn
|
7 |
Peh, K. K., Yuen, K. H., Wong J. W., and Toh, W. T., Comparative bioavailability study of two atenolol tablet preparations. Drug Dev. Ind. Pharm., 25, 357-360 (1999)
DOI
ScienceOn
|
8 |
Yuen, K. H., Peh K. K., and Billa, N., Comparative bioavailability study of a generic naltrexone tablet preparation. Drug Dev. Ind. Pharm., 25, 353-356 (1999)
DOI
ScienceOn
|
9 |
Ghebre-Sellassi, I., Multiarticulate Oral Drug Delivery, Marcel Dekker, New York, (1994)
|
10 |
McGinity, J. W., Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms, Marcel Dekker, New York, (1989)
|
11 |
Bechgaard, H., Brodie, R. R., Chasseaud, L. F., Houmoller, P., Hunter, J. O., Siklos, P., and Taylor, T., Bioavailability of indomethacin from two multiple-units controlled-release formulations. Eur. J. Clin. Pharmacol., 21, 511-515 (1982)
DOI
ScienceOn
|